Skip to main content

Published locations for Alternate 2:1 sunitinib schedule showed safety gains in renal cell carcinoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alternate 2:1 sunitinib schedule showed safety gains in renal cell carcinoma

User login

  • Reset your password
  • /content/alternate-21-sunitinib-schedule-showed-safety-gains-renal-cell-carcinoma
  • /oncologypractice/article/164356/renal-cell-carcinoma/alternate-21-sunitinib-schedule-showed-safety
  • /hematology-oncology/article/164356/renal-cell-carcinoma/alternate-21-sunitinib-schedule-showed